Dr Ruth Thomas

Research Fellow

BSc (Health Sciences), PhD

Dr Ruth Thomas

Contact Details

Telephone: +44 (0)1224 438172
Fax: +44 (0)1224 438165
Email: r.e.thomas@abdn.ac.uk
Address: Centre for Healthcare Randomised Trials (CHaRT) Health Services Research Unit University of Aberdeen 3rd Floor, Health Sciences Building Foresterhill ABERDEEN AB25 2ZD


Ruth Thomas is currently a Research Manager for the Centre Healthcare Randomised Trials (CHaRT), a fully registered UK Clinical Research Collaboration Clinical Trials Unit with an internationally recognised expertise in the design, conduct, analysis and reporting of multicentre trials.  Ruth joined the Unit in 1993.  She completed her PhD in the Unit in 2002 and went on to take up a Wellcome Trust Training Fellowship in Health Services Research which she completed in 2006. Ruth is a Health Services Researcher experienced in a range of HSR methods including systematic reviews, pragmatic RCTs (simple and complex), and other evaluative designs. Ruth previously worked on a series of "knowledge translation" evaluations ie getting evidence into clinical practice, involving complex rigorous designs.  

Current Research

Ongoing research

Previous research

Research Grants

NIHR HS&DR 15/136/07 Multiple Symptoms Study 3: pragmatic trial of a community based clinic for patients with persistent (medically unexplained) physical symptoms. Start date: 1st February 2018 (42 months) Value: £1,193,035

NIHR HTA (13/152/02) The clinical and cost effectiveness of surgical interventions for stones in the lower pole calyces of the kidney: the PUrE RCT - Percutaneous Nephrolithotomy (PNL), Flexible Ureterorenoscopy (FURS) and Extracorporeal Shockwave Lithotripsy (ESWL) for lower pole calyceal kidney stones. Start date: 1st December 2015. (60 months). Value: £1,877,148.56.

Chief Scientists Office of the Scottish Government CZH/4/945 – Multiple Symptoms Study 2. A feasibility study to manualise, teach and demonstrate the delivery of the Symptoms Clinic intervention Start date: April 2014 (12 months). Value: £139,962.

NIHR HTA (10/137/01). Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. Start date: 1st March 2013 (48 months). Value: £1,426,755.

NIHR HTA (08/71/01) SUSPEND: Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multi centre placebo randomised trial. Start date: 1st June 2010 (42 months extended to 53 months). Value: £1,585,180 (+ 132,732).

NIHR HTA (07/47/01). The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer. Start date: 1st June 2008. Value: £239,474.



update | about Staff Pages